DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy - Fujita, H; Taniai, H; Murayama, H (Endocr J, 2014)
et al.